Table 2.
Demographic and clinical-pathologic characteristics.
| Cancer Cases (n = 40) |
Controls (n = 40) |
p | |
|---|---|---|---|
| Age | |||
| 30–65 | 6 (15%) | 12 (30%) | 0.08 |
| 66–70 | 7 (18%) | 12 (30%) | |
| 71–75 | 13 (33%) | 10 (25%) | |
| 76–90 | 14 (35%) | 6 (15%) | |
| Sex | |||
| Male | 36 (90%) | 30 (75%) | 0.14 |
| Female | 4 (10%) | 10 (25%) | |
| Cytology | |||
| Negative | 19 (48%) | ||
| Positive | 13 (33%) | ||
| N/A | 8 (20%) | 40 (100%) | |
| Grade | |||
| Low | 12 (30%) | ||
| High | 21 (53%) | ||
| N/A | 7 (18%) | 40 (100%) | |
| Stage | |||
| Tis | 1 (3%) | ||
| Ta | 21 (53%) | ||
| T1 | 4 (10%) | ||
| T2 | 6 (15%) | ||
| N/A | 8 (20%) | 40 (100%) |
Note. The p-value is for Fisher’s exact test.